We've extended our long-term exclusive partnership with @MaglepharmCept, marking a key step in expanding the global impact of embolization therapies.
This collaboration will drive patient and physician value through clinical program development and new market entry with Magle Group's expertise in manufacturing and DSM technology.
Read more here: https://t.co/XaImHZ47dd
PCE has launched a physical activity & pancreatic cancer video series for people living with pancreatic cancer. 🏋🏽🏀
Video 3 looks at the effects of physical activity.
👉 Watch Video 3 and learn more: https://t.co/Y8P1ZRH85z
Would you like to attend a scientific symposium and learn about the latest innovations and real-world clinical experience in pancreatic and non-pancreatic surgery?
You are invited!
📅 22 January | 5:15–5:50 PM
👉 Register here: https://t.co/kjvi2lExlj
SmartPAN represented at ESSO in Paris!
Last week, at the Advanced Course on Pancreatic Cancer Surgery by the @ESSOnews (4–5 September 2025, Paris, FR), senior residents, fellows, and consultant surgeons from across Europe gathered to advance their expertise in pancreatic surgery
🌍 Lung Cancer Awareness
Behind every diagnosis is a person, a patient with a family offering strength, and a community ready to support.
One supportive option is embolization therapy, which blocks a tumor’s blood supply to help control growth and reduce symptoms.
We are committed to advancing innovative solutions for patients, including EmboCept® S DSM 50 µm, effective short-term chemoembolization microspheres used in the intra-arterial treatment of inoperable lung tumors.
📎Read more WHO Lung Cancer Facts 👉 https://t.co/r4ko117og6
Truly an inspiring experience at European Pancreatic Club #EPC2025 in #Düsseldorf!
A gathering of the pancreatic community, sharing the latest research, updates, and critical discussions around improving care in #pancreaticcancer and #pancreaticSurgery.
👉 Stay tuned